PL2052273T3 - Obrazowanie lub spektroskopia metodą rezonansu magnetycznego 13C śmierci komórkowej - Google Patents

Obrazowanie lub spektroskopia metodą rezonansu magnetycznego 13C śmierci komórkowej

Info

Publication number
PL2052273T3
PL2052273T3 PL07808605T PL07808605T PL2052273T3 PL 2052273 T3 PL2052273 T3 PL 2052273T3 PL 07808605 T PL07808605 T PL 07808605T PL 07808605 T PL07808605 T PL 07808605T PL 2052273 T3 PL2052273 T3 PL 2052273T3
Authority
PL
Poland
Prior art keywords
spectroscopy
cell death
magnetic resonance
resonance imaging
imaging
Prior art date
Application number
PL07808605T
Other languages
English (en)
Inventor
Kevin M Brindle
Samuel Evan Day
Mikko Iivari Kettunen
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of PL2052273T3 publication Critical patent/PL2052273T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4828—Resolving the MR signals of different chemical species, e.g. water-fat imaging

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Signal Processing (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PL07808605T 2006-08-18 2007-08-17 Obrazowanie lub spektroskopia metodą rezonansu magnetycznego 13C śmierci komórkowej PL2052273T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20063702 2006-08-18
EP07808605A EP2052273B1 (en) 2006-08-18 2007-08-17 13c-mr imaging or spectroscopy of cell death
PCT/NO2007/000286 WO2008020764A1 (en) 2006-08-18 2007-08-17 13c-mr imaging or spectroscopy of cell death

Publications (1)

Publication Number Publication Date
PL2052273T3 true PL2052273T3 (pl) 2012-08-31

Family

ID=38690525

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07808605T PL2052273T3 (pl) 2006-08-18 2007-08-17 Obrazowanie lub spektroskopia metodą rezonansu magnetycznego 13C śmierci komórkowej

Country Status (8)

Country Link
US (1) US8951500B2 (pl)
EP (1) EP2052273B1 (pl)
JP (1) JP5363320B2 (pl)
CN (1) CN101506679B (pl)
AT (1) ATE549638T1 (pl)
ES (1) ES2381380T3 (pl)
PL (1) PL2052273T3 (pl)
WO (1) WO2008020764A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2051739A2 (en) * 2006-08-18 2009-04-29 GE Healthcare AS Imaging medium comprising lactate and hyperpolarised 13c-pyruvate
US20100016706A1 (en) * 2006-12-08 2010-01-21 Molecular Image, Inc. Methods for diagnosis and monitoring of neurologic diseases using magnetic resonance methods
GB0713074D0 (en) 2007-07-05 2007-08-15 Univ London A method of hyperpolarising a magnetic resonance agent
BRPI1013677A2 (pt) * 2009-04-02 2016-04-26 Ge Healthcare Ltd método para detectar inflamação ou infecção, e, usos de um 13c-piruvato hiperpolarizado, e de um meio de formação de imagem.
US20130209360A1 (en) * 2010-08-23 2013-08-15 The Regents Of The University Of California Compositions and Methods for Imaging
WO2012145733A1 (en) 2011-04-22 2012-10-26 Vanderbilt University Para-hydrogen polarizer
EP2950826B1 (en) 2013-01-31 2019-09-18 Bracco Imaging S.p.A Hyperpolarized esters as metabolic markers in mri
EP3016687B1 (en) * 2013-07-01 2017-08-09 Bracco Imaging S.p.A Hyperpolarized 1-13c-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for mr
EP2863229A1 (en) 2013-10-15 2015-04-22 Technische Universität München pH-biosensors based on compounds with pH-sensitive enolic groups for magnetic resonance imaging and spectroscopy and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
AU783283B2 (en) * 1999-08-30 2005-10-13 Ester C Company, The Methods and compositions for selective cancer chemotherapy
CA2576202A1 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
PL1824523T3 (pl) * 2004-11-19 2013-12-31 Ge Healthcare As Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu

Also Published As

Publication number Publication date
EP2052273B1 (en) 2012-03-14
CN101506679A (zh) 2009-08-12
ATE549638T1 (de) 2012-03-15
EP2052273A1 (en) 2009-04-29
WO2008020764A1 (en) 2008-02-21
US20100226859A1 (en) 2010-09-09
JP5363320B2 (ja) 2013-12-11
ES2381380T3 (es) 2012-05-25
US8951500B2 (en) 2015-02-10
CN101506679B (zh) 2013-03-06
JP2010501482A (ja) 2010-01-21

Similar Documents

Publication Publication Date Title
IL184327A (en) Probe for assessment of magnetic field distortion
NL1032695A1 (nl) Magnetische-resonantiebeeldvormingsapparatuur en -werkwijze.
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
NL1033060A1 (nl) Magnetische-resonantiebeeldvormingsapparatuur en -werkwijze.
EP1869617A4 (en) METHOD AND SYSTEM FOR ESTABLISHING THE PRICE OF FINANCIAL INSTRUMENTS
NL2000185A1 (nl) Transporteerbaar magnetisch-resonantie-beeldvormings (MRI)-systeem.
MX353984B (es) Anticuerpos multi-especificos.
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
GB2427694B (en) Systems, methods and apparatus of an actively shielded superconducting magnet drift compensation coil
NL2003304A1 (nl) Compensation of Dose Inhomogeneity and Image Distortion.
NL2002411A1 (nl) System and method for tissue specific MR imaging of metabolites using spectral-spatially formed stimulated echo.
CY1113074T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
GB0502651D0 (en) Methods and apparatus for measuring the internal structure of an object
TW200640924A (en) VEGF-R2 inhibitors and methods
NL2002313A1 (nl) System and method for extracting features of interest from an image.
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
EP1876958A4 (en) METHOD AND PROBE OF DOUBLE-NETWORK TRANSDUCER FOR MECHANICAL IMAGING OF PROSTATE IN REAL-TIME
DE602006018835D1 (de) Verfahren und System zur Ermittlung des Datenübertragungsmodus eines Zugangspunktes
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
GEP20125586B (en) Novel method for synthesis of (7-methoxy-l-naphthyl)-acetonitrile and application thereof in synthesis of agomelatine
EP2539896A4 (en) STRUCTURE WITH HIGH GMR AND FEW CONTROL FIELDS
DE602007009336D1 (de) Vergrösserung des Signal-zu-Rausch-Verhältnisses in der spektroskopischen Bilderzeugung mittels magnetischer Resonanz
NL2001184A1 (nl) Systeem en werkwijze voor metabolische MR-afbeelding van een hypergepolariseerd middel.
ATE544474T1 (de) Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird